Using bioluminescence imaging system, we found that the volume of intracranial tumor xenografts were markedly reduced by the silencing of LINC00520, while a significant progression in tumor growth was observed in the si-NC group (P < 0.001) (Fig. 6B). The gene discussed is LINC00520; the disease is neoplasm.